Synchronous primary tumors amd distant metastasis detected on 18F-FDG PET in patients with head and neck carcinoma

Document Type : Original Article

Authors

1 Department of Nuclear medicine, Dr Rajendra Prasad Government medical college,Tanda Kangra Himachal Pradesh, India

2 Department of Nuclear medicine, Shree Balaji superspeciality hospital, Kangra Himachal Pradesh, India

Abstract

Objective(s): 18F-FDG PET/CT has been used to characterize the primary lesion and staging in head and neck cancers (HNC). However, prior studies for detecting distant metastasis and  synchronous tumors are sparse, especially in Indian context. To investigate the frequency and distribution of head and neck carcinomas, distant metastases and synchronous malignancies detected in HNC in a north Indian population.
Methods: Medical records and whole body 18F-FDG PET/CT examinations performed for initial staging on a total of 281 newly diagnosed HNC patients between 01/2019 to 31/6/2023 in North India were retrospectively analyzed and reviewed to look for distant metastasis and synchronous tumors.
Results: On whole body 18F-FDG PET/CT, distant metastases were detected in 33 (11.7%) patients, all with locally advanced primary tumors corresponding to T category 3 and 4. Lung (6%) and bone (~6.7%) were the most common sites of distant metastasis. In nine patients metastases were detected below the diaphragm. Synchronous malignancies were discovered and histopathologically proven in 22 (7%) patients. Lung carcinoma was the most common synchronous tumor, detected in 9 patients.  In seven patients synchronous tumour was detected outside the aerodigestive tract, of which four were below the diaphragm.
Conclusions: Of the distant metastasis diagnosed in 11.7% of HNC patients with TNM  tumor category T3 and T4, 3% of metastasis lesions were detected below the diaphragm.  Synchronous malignancy was diagnosed in 7% patients irrespective of primary HNC stage.  These findings demonstrate the advantage of using whole body 18F-FDG PET/CT as an ideal and preferred modality for initial staging and screening of HNC patients since detection of distant metastasis or a synchronous malignancy changes the management approach in these patients.

Keywords

Main Subjects

References

  1. Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology. 2017; 3(4):524.
  2. Shankar VM, Shetty RS, Salins SL, Mallya SD, Kunder MA, Bhat V, et al. IJCM_150A: A profile of Head and Neck Cancer patients attending a tertiary cancer care centre in Southern Karnataka. Indian Journal of Community Medicine. 2024; 49(Suppl 1): S44.
  3. Xu GZ, Guan DJ, He ZY. 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral oncology. 2011; 47(7):560-5.
  4. Rohde M, Nielsen AL, Johansen J, Sørensen JA, Nguyen N, Diaz A, et al. Head-to-head comparison of chest x-ray/head and neck MRI, chest CT/head and neck MRI, and 18F-FDG PET/CT for detection of distant metastases and synchronous cancer in oral, pharyngeal, and laryngeal cancer. Journal of Nuclear Medicine. 2017; 58(12):1919-24.
  5. Park MJ, Oh JS, Roh JL, Kim JS, Lee JH, Nam SY, et al. 18F-FDG PET/CT versus contrast-enhanced CT for staging and prognostic prediction in patients with salivary gland carcinomas. Clinical Nuclear Medicine. 2017; 42(3):e149-56.
  6. Deurvorst SE, Hoekstra OS, Castelijns JA, Witte BI, Leemans CR, De Bree R. Clinical value of 18FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma. Clinical Otolaryngology. 2018; 43(3):875-81.
  7. Mazeau-Woynar V, Cerf N. Expected Survival of Cancer Patients In France: Current Situation. Paris: INCA. 2015.
  8. Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study. BMC Cancer. 2014; 14: 272.
  9. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995; 75(6):1343-53.
  10. Haughey BH, Arfken CL, Gates GA, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Annals of Otology, Rhinology & Laryngology. 1992; 101(2):105-12.
  11. Ryu IS, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Impact of 18F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. European Journal of Cancer. 2016; 63: 88-96.
  12. Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, et al. Update of the recommendations of good clinical practice for the use of PET in oncology. Bulletin du Cancer. 2019; 106(3): 262-74.
  13. Brierley JD, Gospodarowicz MK, Wittekind C, editors. UICC TNM classification of malignant tumours. 8th Chichester: Wiley Blackwell, 2017.
  14. Warren S. Multiple primary malignant tumors: a survey of the literature. Am J Cancer. 1932; 16: 1358-414.
  15. Siddiqui MS, Chandra R, Aziz A, Suman S. Epidemiology and histopathological spectrum of head and neck cancers in Bihar, a state of Eastern India. Asian Pacific journal of cancer prevention. 2012; 13(8): 3949-53.
  16. Mishra A, Singh VP, Verma V. Environmental effects on head and neck cancer in India. Journal of clinical oncology. 2009; 27(15_suppl): e17059.
  17. Kekatpure V, Kuriakose MA. Oral Cancer in India: Learning from different populations. National newsletter and website from New York Presbyterian Hospital 2010; 14.
  18. Linz C, Brands RC, Hackenberg S, Hartmann S, Iring T, Hohm J, et al. [18F] FDG-PET/CT improves the detection of synchronous malignancies at primary staging of oral squamous cell carcinoma–A retrospective study. Journal of Cranio-Maxillofacial Surgery. 2022; 50(8): 671-6.
  19. Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF. Head and neck squamous cell carcinoma (HNSCC)–detection of synchronous primaries with 18F-FDG-PET/CT. European journal of nuclear medicine and molecular imaging. 2009; 36:919-27.
  20. Lee HS, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY. Clinical values for abnormal 18F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma. European Journal of Radiology. 2014; 83(8): 1455-60.
  21. Gandla S, Rao V. Role of PET CT in the detection of second synchronous primary tumors and distant metastasis in head and neck cancers at initial presentation. International Journal of Otorhino-laryngology and Head and Neck Surgery. 2019; 5(2): 391.
  22. Györke T, Duffek L, Bártfai K, Makó E, Karlinger K, Mester Á, et al. The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aspecific bowel activity using immuno-scintigraphy with 99mTc anti-granulocyte antibodies. European journal of radiology. 2000; 35(3):183-92.
  23. Leclere JC, Delcroix O, Rousset J, Valette G, Robin P, Guezennec C, et al. Integration of 18-FDG PET/CT in the initial work-up to stage head and neck cancer: prognostic significance and impact on therapeutic decision making. Frontiers in Medicine. 2020; 7:273.
  24. Alok A, Singh ID, Panat SR, Singh S, Kishore M. Oral field cancerization: A review. Int J Dent Med Res. 2014; 1(3): 98-104.
  25. Graff P, Schipman B, Desandes E, Mecellem H, Toussaint B, Cortese S, et al. Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site. Clinical Oncology. 2011; 23(3): 174-81.
  26. Gandla S, Rao V. Role of PET CT in the detection of second synchronous primary tumors and distant metastasis in head and neck cancers at initial presentation. International Journal of Otorhino-laryngology and Head and Neck Surgery. 2019; 5(2): 391.
Asia Oceania Journal of Nuclear Medicine and Biology
Volume 13, Issue 1
January 2025
Pages 21-32

Files

Share

How to cite

Statistics